Junliang Lu

1.4k total citations
48 papers, 961 citations indexed

About

Junliang Lu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Junliang Lu has authored 48 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Junliang Lu's work include Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Junliang Lu is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Junliang Lu collaborates with scholars based in China, United States and India. Junliang Lu's co-authors include Zhiyong Liang, Huanwen Wu, Jian Sun, Huanli Duan, Tonghua Liu, Hui Zhang, Lili Wang, Xinyu Ren, Tao Lu and Jie Gao and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Junliang Lu

46 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junliang Lu China 18 435 334 253 185 178 48 961
Sung‐Im Do South Korea 16 340 0.8× 399 1.2× 258 1.0× 175 0.9× 127 0.7× 84 913
Su Hwan Kang South Korea 14 452 1.0× 226 0.7× 358 1.4× 160 0.9× 144 0.8× 59 842
Janine Soares Portugal 23 458 1.1× 282 0.8× 208 0.8× 155 0.8× 306 1.7× 49 1.2k
Younghye Kim South Korea 13 251 0.6× 247 0.7× 122 0.5× 133 0.7× 180 1.0× 30 817
Fernando Pardal Portugal 16 236 0.5× 404 1.2× 211 0.8× 123 0.7× 136 0.8× 26 829
Alessandra Bisagni Italy 16 285 0.7× 172 0.5× 124 0.5× 259 1.4× 134 0.8× 51 765
Isabella Morra Italy 19 296 0.7× 412 1.2× 293 1.2× 179 1.0× 69 0.4× 43 1.2k
Wook Youn Kim South Korea 16 403 0.9× 233 0.7× 164 0.6× 73 0.4× 354 2.0× 49 925
C. Soon Lee Australia 20 364 0.8× 325 1.0× 240 0.9× 153 0.8× 298 1.7× 39 1.0k
Volkert B. Wreesmann United States 22 424 1.0× 440 1.3× 151 0.6× 131 0.7× 198 1.1× 32 1.4k

Countries citing papers authored by Junliang Lu

Since Specialization
Citations

This map shows the geographic impact of Junliang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Lu more than expected).

Fields of papers citing papers by Junliang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junliang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Lu. The network helps show where Junliang Lu may publish in the future.

Co-authorship network of co-authors of Junliang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Junliang Lu. A scholar is included among the top collaborators of Junliang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junliang Lu. Junliang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Junliang, Liangrui Zhou, Taiping Zhang, et al.. (2025). Molecular profiling reveals the malignant potential in solid pseudopapillary neoplasms of the pancreas. Cancer Letters. 625. 217788–217788. 1 indexed citations
2.
Pang, Junyi, Yang Zhou, Junliang Lu, et al.. (2025). FRα expression in advanced endometrial carcinoma: Clinicopathological, molecular, and prognosis correlates. Gynecologic Oncology. 197. 146–154.
3.
Lu, Junliang, Zongzhan Gao, Wei He, & Yao Lu. (2025). Harnessing the potential of hyaluronic acid methacrylate (HAMA) hydrogel for clinical applications in orthopaedic diseases. Journal of Orthopaedic Translation. 50. 111–128. 8 indexed citations
5.
Wang, Hao, Junliang Lu, Junyi Pang, et al.. (2024). Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants. Translational Lung Cancer Research. 13(12). 3538–3554. 1 indexed citations
7.
Chen, Lingfeng, Lili Fu, Jingchuan Sun, et al.. (2023). Structural basis for FGF hormone signalling. Nature. 618(7966). 862–870. 68 indexed citations
8.
Zhang, Zijuan, Junliang Lu, Hui Zhang, et al.. (2023). A Comprehensive Study of Heterogeneous Mismatch Repair Expression in Solid Tumors Reveals Different Immunohistochemical Patterns and Distinct Genetic Mechanisms. The American Journal of Surgical Pathology. 48(4). 417–425. 2 indexed citations
9.
Wang, Pan, Junliang Lu, Boju Pan, et al.. (2022). Diagnostic significance of parafibromin expression in parathyroid carcinoma. Human Pathology. 127. 28–38. 9 indexed citations
10.
Wang, Jing, Ruiyu Li, Junjie Li, et al.. (2021). Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing. Journal of Translational Medicine. 19(1). 433–433. 11 indexed citations
11.
Wang, Xianze, Hao Chen, Rui Jiang, et al.. (2021). Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Letters. 508. 1–12. 16 indexed citations
12.
Lu, Junliang, Ruoying Yu, Rui Liu, et al.. (2020). Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes. Cancer Medicine. 10(3). 933–943. 13 indexed citations
13.
Xiao, Ying, Hui Zhang, Qiang Ma, et al.. (2019). YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation. Cancer Letters. 462. 51–60. 45 indexed citations
14.
Liang, Xiaolong, Jian Sun, Huanwen Wu, et al.. (2018). PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay. Diagnostic Pathology. 13(1). 5–5. 29 indexed citations
16.
Shi, Xiaohua, Huanwen Wu, Junliang Lu, et al.. (2016). Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods. Scientific Reports. 6(1). 22297–22297. 20 indexed citations
17.
Ren, Xinyu, et al.. (2016). c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer. Tumor Biology. 37(8). 11385–11395. 12 indexed citations
18.
Lu, Junliang, Jie Gao, Jing Zhang, et al.. (2015). Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.. PubMed. 8(1). 793–9. 27 indexed citations
19.
Zhang, Jing, Jianming Zheng, Yinghong Yang, et al.. (2015). Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Scientific Reports. 5(1). 18678–18678. 97 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026